Companies · Other Health Care

Nova Oculus Partners, Llc

PALM DESERT · Other Health Care

Diligence memoA one-page analyst read on Nova Oculus Partners, Llc — recommendation, valuation, rhythm, risks.
$14.4M
Total raised · real
7
Rounds
1.1×
Latest step-up
Top 21%
Sector rank · raised
Series A
Latest stage · inferred · Thu Jul 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Nova Oculus Partners, Llc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.18× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
  • Within the normal band (118% of peer median) for its niche.
Dormant
  • Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Nova Oculus Partners, Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
12.1 yr record
Peak capital year was 2020 with $6.0M across 1 filings.
Market position
ahead of 80% of Other Health Care peers
Capital scale is ahead of 80% of Other Health Care peers; modeled value is above 82% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2020: $6.0M across 1 filings.
  • Largest single filing was $6.0M on 2020-07-16.
  • Filing rows sum to $15.7M, while canonical raised total is $14.4M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Nova Oculus Partners, Llc is one of 5376 Other Health Care companies tracked from PALM DESERT. By capital raised it ranks in the upper tier (ahead of 80% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 506(c)
Reg D exemption
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MPre-Seed · 2014-06-11 Raised $648K (real) Modeled valuation $20M (est)Pre-Seed2014Pre-Seed · 2015-04-23 Raised $100K (real) Modeled valuation $3.1M (est)Pre-Seed2015Seed · 2016-03-31 Raised $1.8M (real) Modeled valuation $44M (est)Seed2016Seed · 2016-04-22 Raised $170K (real) Modeled valuation $4.2M (est)Seed2016Pre-Seed · 2016-04-22 Raised $365K (real) Modeled valuation $11M (est)Pre-Seed2016Seed · 2017-03-30 Raised $119K (real) Modeled valuation $3.0M (est)Seed2017Seed · 2018-02-05 Raised $265K (real) Modeled valuation $6.6M (est)Seed2018Pre-Seed · 2018-02-05 Raised $250K (real) Modeled valuation $7.7M (est)Pre-Seed2018Pre-Seed · 2018-02-05 Raised $250K (real) Modeled valuation $7.7M (est)Pre-Seed2018Pre-Seed · 2018-02-05 Raised $250K (real) Modeled valuation $7.7M (est)Pre-Seed2018Series A · 2019-07-01 Raised $5.5M (real) Modeled valuation $111M (est)Series A2019Series A · 2020-07-16 Raised $6.0M (real) Modeled valuation $119M (est)Series A2020Cumulative $16M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$648K · 2014
Pre-Seed extension$100K · 2015
Seed$1.8M · 2016
Seed extension$170K · 2016
Bridge · Seed-stage$365K · 2016smaller follow-on
Seed extension$119K · 2017
Seed extension$265K · 2018
Bridge · Seed-stage$250K · 2018smaller follow-on
Bridge · Seed-stage$250K · 2018smaller follow-on
Bridge · Seed-stage$250K · 2018smaller follow-on
Series A$5.5M · 2019
Series A extension$6.0M · 2020

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$119.2M
Base estimate est.
$7.7M
Conservative case
$642.1M
Upside case
$27.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $20.0M · 2014-06-112014Pre-Seed · modeled $3.1M · 2015-04-23Seed · modeled $44.4M · 2016-03-31Seed · modeled $4.2M · 2016-04-22Pre-Seed · modeled $11.2M · 2016-04-22Seed · modeled $3.0M · 2017-03-30Seed · modeled $6.6M · 2018-02-05Pre-Seed · modeled $7.7M · 2018-02-05Pre-Seed · modeled $7.7M · 2018-02-05Pre-Seed · modeled $7.7M · 2018-02-05Series A · modeled $111.0M · 2019-07-01Series A · modeled $119.2M · 2020-07-162020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
7 mo
Avg between rounds
$2.4M/yr
Capital velocity
12.1 yr
On record since
2014
First round
12
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.9× above median
This company$14.4M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 1.1× above median
This company$6.0M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 5.4× above median
This company$119.2M
Sector median$22.1M

Raised more than 80% of sector peers (real $). Modeled value above 82% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #57 of 164.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $259.8M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.4M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.1M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.3M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)Nova Oculus Partners, Llc (this company) Raised $14.4M · modeled $119.2M (est)Nova Oculus Partners, Llc
CompanyStageRaised · realValue · estvs peer med.
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$259.8M2.57×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.4M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.1M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.3M2.19×
Zipari, Inc.Series A$29.6M$208.3M2.06×
Nova Oculus Partners, Llc this companySeries A$14.4M$119.2M1.18×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$648K2014-06-11$3.6M$20.0M85%
Pre-Seed$100K2015-04-23$556K$3.1M85%
Seed$1.8M2016-03-31$8.9M$44.4M85%
Seed$170K2016-04-22$850K$4.2M85%
Pre-Seed$365K2016-04-22$2.0M$11.2M85%
Seed$119K2017-03-30$597K$3.0M90%
Seed$265K2018-02-05$1.3M$6.6M90%
Pre-Seed$250K2018-02-05$1.4M$7.7M90%
Pre-Seed$250K2018-02-05$1.4M$7.7M90%
Pre-Seed$250K2018-02-05$1.4M$7.7M90%
Series A$5.5M2019-07-01$25.0M$111.0M90%
Series A$6.0M2020-07-16$27.3M$119.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$648K2014-06-11
    • First recorded raise — entered as Pre-Seed.
    • 22 investors on this round.
  2. Pre-Seed$100K2015-04-23
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 6.5× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  3. Seed$1.8M2016-03-31
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 17.9× larger than the prior — scaling up.
    • 47 investors on this round.
  4. Seed$170K2016-04-22
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 10.5× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  5. Pre-Seed$365K2016-04-22
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 13 investors on this round.
  6. Seed$119K2017-03-30
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 3.1× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  7. Seed$265K2018-02-05
    • Raised 10 mo later, in step with the ~14 mo sector norm.
    • Round 2.2× larger than the prior — scaling up.
    • 7 investors on this round.
  8. Pre-Seed$250K2018-02-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
  9. Pre-Seed$250K2018-02-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
  10. Pre-Seed$250K2018-02-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
  11. Series A$5.5M2019-07-01
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round 22.0× larger than the prior — scaling up.
  12. Series A$6.0M2020-07-16
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
Intelligence
2021 ~Q1
Modeled next raise · ~7mo cadence
$6.5M
Modeled next size est.range $6.0M$10.5M
1.1×
Last step-up
$2.4M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
PETER POCKLINGTON1 other2017-03
GEORGE O'CLOCK2018-02
LANTSON ELDRED2014-06
MIKE SAMUEL2018-02
WALTER O'ROURKE2017-03
Registry & provenance

Nova Oculus Partners, Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1616856
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Celleration IncOther Health CareSeries A$14.4M$129.7Msame sector · same stage
Post Acute Recovery, Inc.Other Health CareSeries A$14.5M$122.9Msame sector · same stage
RevMedica, Inc.Other Health CareSeries A$14.2M$101.1Msame sector · same stage
Micro Interventional Devices, Inc.Other Health CareSeries A$14.0M$118.9Msame sector · same stage
American Addiction Centers, Inc.Other Health CareSeries A$14.9M$121.5Msame sector · same stage
OC Medical Holdings, Inc.Other Health CareSeries A$15.0M$100.9Msame sector · same stage
Syncardia Systems IncOther Health CareSeries A$15.0M$129.5Msame sector · same stage
CDx, Inc.Other Health CareSeries A$13.8M$139.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
VirtualCare, LLCOther Health CarePre-Seed$15.4M85%
Virtual Health Partners, Inc.HealthtechSeed$43.1M85%
Novaestiq Corp.Other Health CareSeries A$100.7M85%
Novascan Inc.Other Health CareSeries A$25.5M84%
Vrhspv LlcOther Health CarePre-Seed$475K84%
NovaSom, IncOther Health CareSeries B$82.0M83%
Virtual Frameworks, Inc.Other Health CareSeries A$141.3M82%
Vyvve, LLCOther Health CareSeed$26.5M82%
Frequently asked
How much funding has Nova Oculus Partners, Llc raised?
Nova Oculus Partners, Llc has raised approximately $14.4M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Nova Oculus Partners, Llc's estimated valuation?
Provath's modeled valuation for Nova Oculus Partners, Llc is approximately $119.2M (modeled range $7.7M–$642.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Nova Oculus Partners, Llc at?
Nova Oculus Partners, Llc's latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Jul 16.
What does Nova Oculus Partners, Llc do and where is it based?
Nova Oculus Partners, Llc operates in the Other Health Care sector, based in PALM DESERT.
Explore related

See where Nova Oculus Partners, Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Nova Oculus Partners, Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.